BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/28/2016 3:05:00 PM | Browse: 1145 | Download: 1397
|
Received |
|
2015-12-29 09:07 |
|
Peer-Review Started |
|
2015-12-30 14:50 |
|
To Make the First Decision |
|
2016-01-28 15:06 |
|
Return for Revision |
|
2016-01-29 19:04 |
|
Revised |
|
2016-02-09 16:58 |
|
Second Decision |
|
2016-02-23 09:32 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2016-03-02 10:38 |
|
Articles in Press |
|
2016-03-02 10:38 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2016-03-16 11:22 |
|
Publish the Manuscript Online |
|
2016-03-28 15:05 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Meta-Analysis |
Article Title |
Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?
|
Manuscript Source |
Invited Manuscript |
All Author List |
Nick E Burr, Mark A Hull and Venkataraman Subramanian |
Funding Agency and Grant Number |
|
Corresponding Author |
Dr. Venkataraman Subramanian, MD, DM, MRCP, Leeds Institute for Biomedical and Clinical Sciences, St James’s University Hospital, University of Leeds, LS9 7TF Leeds, United Kingdom. nick.burr@nhs.net
|
Key Words |
Inflammatory bowel disease; Aspirin; Non-steroidal anti-inflammatory; Colorectal cancer; Chemoprevention |
Core Tip |
Colorectal cancer (CRC) remains a serious complication of inflammatory bowel disease (IBD) and chemoprevention is an attractive alternative to prophylactic surgery or intensive surveillance programs. Aspirin and non-steroidal anti-inflammatory drugs have chemopreventative activity against “sporadic” CRC. We have synthesized the available data for the prevention of IBD associated CRC and found no potential protective effect for either medication. There is a lack of available data on the potential effects of these medications in preventing CRC in patients with IBD and there is a need for high quality, focused studies on this topic.
|
Publish Date |
2016-03-28 15:05 |
Citation |
Burr NE, Hull MA, Subramanian V. Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease? World J Gastroenterol 2016; 22(13): 3679-3686 |
URL |
http://www.wjgnet.com/1007-9327/full/v22/i13/3679.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v22.i13.3679 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345